GE Healthcare played to high-field enthusiasts visiting the RSNA exhibit floor Sunday, unveiling three MR scanners – one at 3T and two at 1.5T.
GE Healthcare played to high-field enthusiasts visiting the RSNA exhibit floor Sunday, unveiling three MR scanners - one at 3T and two at 1.5T.
The Signa HDx 3T and Signa HDx 1.5T are built on a 32-channel architecture and support advanced clinical applications, including PROPELLER for motion-resistant brain imaging, VIBRANT-XV breast scanning, LAVA-XV body imaging, and TRICKS-XV time-resolved angiography. The Signa HDe, a value-driven 1.5T scanner, comes in four- and eight-channel configurations, and sports a small footprint for easy installation.
The 3T and premium 1.5T systems feature a new XVRE reconstruction engine; advanced parallel imaging algorithms; new acquisition strategies; and an interlocking, high-density head, neck, and spine coil system.
Signa HDx 3T utilizes high-density coils developed for the company's previously launched HD 3T system, which will remain in the GE line-up. New this year is the Signa HD breast coil, which supports multi-dimensional parallel imaging and biopsy capability, and a high-density hybrid extremity coil.
Signa HDx takes the flagship position in GE's 1.5T portfolio. It utilizes a Signa HD peripheral vascular lower leg array, which provides images of the lower leg and foot vessels.
The value-oriented Signa HDe 1.5T builds on the high definition platform, but offers lower operating costs and requires less overall siting space. With a 30% smaller footprint than a typical 1.5T system, the scanner can be sited where most 1.5T MR systems cannot, according to the company. Installation can be performed in about one week.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.